<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-posttype.xsl?ver=5.7.3"?>
<!-- generated-on="2026-04-30T02:07:03+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.3" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" >
<url><loc>https://amyloidosisnewstoday.com/news/rising-healthcare-costs-strain-eu-budgets-even-as-new-therapies-flourish/</loc><lastmod>2018-12-21T07:00:32-06:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/12/ES-060-470x470.jpg</image:loc><image:title><![CDATA[Europharma]]></image:title><image:caption><![CDATA[From left: Shire&#039;s Andreas Busch; uniQure&#039;s Sander van Deventer; Pfizer&#039;s Gregory LaRosa and Genzyme&#039;s Carlo Incerti speak at a panel during WODC 2018 in Barcelona. (Photo by Larry Luxner)]]></image:caption></image:image><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/12/ES-060-470x470.jpg</image:loc><image:title><![CDATA[Europharma]]></image:title><image:caption><![CDATA[From left: Shire&apos;s Andreas Busch; uniQure&apos;s Sander van Deventer; Pfizer&apos;s Gregory LaRosa and Genzyme&apos;s Carlo Incerti speak at a panel during WODC 2018 in Barcelona. (Photo by Larry Luxner)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/val30met-mutation-patients-differ-endemic-areas-japan/</loc><lastmod>2018-12-20T11:50:43-06:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/patients-france-fap-upper-limb-nerve-damage-often-misdiagnosed-study-suggests/</loc><lastmod>2018-12-13T09:15:53-06:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/fap-diagnosis-worth-considering-patients-neuropathy-cardiac-eye-defects/</loc><lastmod>2018-12-04T12:03:57-06:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/researchers-report-case-of-fap-with-chronic-dry-cough-in-chinese-family/</loc><lastmod>2018-11-29T08:40:37-06:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/liver-transplant-vyndaqel-prolong-survival-early-stage-fap-patients-study/</loc><lastmod>2018-11-15T11:17:43-06:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/val30met-fap-patients-loss-sensation-occurs-both-limbs-study/</loc><lastmod>2018-11-06T10:34:31-06:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/09/shutterstock_549067045_zpsskx2dvtd.jpg</image:loc><image:title><![CDATA[shutterstock_549067045_zpsskx2dvtd]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/lengthening-amyloid-fibrils-may-lead-nerve-cell-loss-fap-study/</loc><lastmod>2018-11-01T10:44:17-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/nordsummit-major-issues-on-table-for-rare-disease-patients-in-us-as-midterm-elections-approach/</loc><lastmod>2018-10-30T08:30:40-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/10/admin-ajax.jpg</image:loc><image:title><![CDATA[NORD Summit]]></image:title><image:caption><![CDATA[Displays at the NORD Summit in Washington, D.C., offer basic facts about rare diseases. (Photo by Larry Luxner)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/fap-not-common-in-patients-with-charcot-marie-tooth-disease-type-2-study-reports/</loc><lastmod>2018-10-23T14:18:44-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/tegsedi-and-onpattro-may-ably-treat-fap-hattr-but-are-overpriced-icer-reports/</loc><lastmod>2018-10-19T07:00:04-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/10/shutterstock_690676162.jpg</image:loc><image:title><![CDATA[shutterstock_690676162]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/fda-approves-tegsedi-fap-treatment-adults/</loc><lastmod>2018-10-15T09:45:48-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/tegsedi-now-approved-canada-treatment-fap-adults/</loc><lastmod>2018-10-11T13:38:40-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/advocacy-groups-doctors-question-rising-prices-of-rare-disease-treatments/</loc><lastmod>2018-10-09T07:40:16-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/10/shutterstock_232219519.jpg</image:loc><image:title><![CDATA[shutterstock_232219519]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/alnylam-submits-new-drug-application-in-japan-for-patisiran-for-treatment-of-hereditary-attr-amyloidosis/</loc><lastmod>2018-10-08T11:06:32-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/nordsummit-more-than-700-expected-to-attend-oct-15-16-rare-disease-summit-in-washington/</loc><lastmod>2018-09-21T10:59:17-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/09/NORD-poster.jpg</image:loc><image:title><![CDATA[NORD poster]]></image:title><image:caption><![CDATA[Participants chat on the sidelines of NORD’s 2017 rare disease summit. (Photo: Larry Luxner)
]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/sensation-testing-could-help-diagnose-fap-boost-outcomes-after-liver-transplant-study-finds/</loc><lastmod>2018-09-20T08:29:30-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/rare-case-fap-ttr-amyloidosis-and-mitochondrial-disease-reported/</loc><lastmod>2018-09-18T10:58:51-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/09/shutterstock_129093140_zpslnndmepu.jpg</image:loc><image:title><![CDATA[shutterstock_129093140_zpslnndmepu]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/somatostatin-analogues-may-ease-chronic-diarrhea-in-familial-amyloid-polyneuropathy-patients-study-reports/</loc><lastmod>2018-09-11T10:49:01-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/09/shutterstock_727606792_zpsgbjwkjbb.jpg</image:loc><image:title><![CDATA[shutterstock_727606792_zpsgbjwkjbb]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/ttr-fap-prevalence-highest-portugal-incidence-decreasing-study/</loc><lastmod>2018-09-04T09:30:30-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/08/Portugal-1.jpg</image:loc><image:title><![CDATA[Portugal-1]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/3d-structure-fap-protein-transthyretin-determines-cellular-effects/</loc><lastmod>2018-08-30T08:47:37-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/blood-vessel-response-vasodilator-determines-fap-severity-study/</loc><lastmod>2018-08-28T09:44:57-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/08/shutterstock_737084134_zpsckimd0hd-1.jpg</image:loc><image:title><![CDATA[shutterstock_737084134_zpsckimd0hd (1)]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/sudoscan-neuropad-distinguish-disease-severity-fap-patients-study-reports/</loc><lastmod>2018-08-23T09:10:54-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/considerable-burden-of-attr-affects-patients-and-caregivers-alike-study-finds/</loc><lastmod>2018-08-21T09:42:01-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/fda-approves-alnylams-onpattro-patisiran-fap-therapy/</loc><lastmod>2018-08-14T09:08:43-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/sudoscan-reliable-accurate-assessing-peripheral-neuropathies-study/</loc><lastmod>2018-08-07T12:38:45-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/08/shutterstock_520979968.jpg</image:loc><image:title><![CDATA[shutterstock_520979968]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/management-fap-patients-should-include-family-therapy/</loc><lastmod>2018-08-02T09:41:38-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/08/familypicture1.jpg</image:loc><image:title><![CDATA[familypicture1]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/vyndaqel-may-ease-cns-eye-manifestations-fap-patients-val30met-mutation/</loc><lastmod>2018-07-31T12:54:18-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/07/results-2.jpg</image:loc><image:title><![CDATA[results 2]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/next-generation-sequencing-gene-analysis-could-improve-fap-diagnosis/</loc><lastmod>2018-07-27T10:11:16-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/07/shutterstock_430949605.jpg</image:loc><image:title><![CDATA[shutterstock_430949605]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/new-data-apollo-study-supports-patisiran-promising-fap-therapy/</loc><lastmod>2018-07-24T11:33:30-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/non-val30met-patients-exhibit-cardiac-blood-vessel-dysfunction-study/</loc><lastmod>2018-07-19T08:05:14-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/07/shutterstock_277872395_zpsetd2jjgj.jpg</image:loc><image:title><![CDATA[shutterstock_277872395_zpsetd2jjgj]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/tegsedi-improves-neuropathy-quality-of-life-fap-patients-clinical-trial/</loc><lastmod>2018-07-17T15:19:20-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/tegsedi-approved-in-european-union-to-treat-stage-1-2-polyneuropathy-in-fap-patients/</loc><lastmod>2018-07-12T11:30:12-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/fap-trial-results-supporting-benefits-patisiran-published-nejm/</loc><lastmod>2018-07-11T08:29:21-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/rare-case-fap-patient-with-heart-failure-fluid-accumulation/</loc><lastmod>2018-07-03T14:59:48-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/06/shutterstock_767578168.jpg</image:loc><image:title><![CDATA[shutterstock_767578168]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/fap-progression-curbed-vyndaqel-liver-transplant-equally/</loc><lastmod>2018-06-26T13:40:44-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/06/shutterstock_391089688.jpg</image:loc><image:title><![CDATA[shutterstock_391089688]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/researchers-identify-unique-fap-predictors-analysis/</loc><lastmod>2018-06-19T10:06:12-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/rare-case-upper-limb-symptoms-preceded-fap-val30met-diagnosis/</loc><lastmod>2018-06-14T12:14:54-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/06/shutterstock_696833128.jpg</image:loc><image:title><![CDATA[shutterstock_696833128]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/noninvasive-sudoscan-device-may-help-assess-fap-severity-in-patients/</loc><lastmod>2018-06-12T12:35:56-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/eye-blood-vessel-alterations-common-in-fap-from-val30met-mutation/</loc><lastmod>2022-07-05T14:49:57-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/9528/</loc><lastmod>2018-06-05T11:50:25-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/06/RTTfeature.jpg</image:loc><image:title><![CDATA[RTTfeature]]></image:title><image:caption><![CDATA[President Trump kisses Jordan McLinn after signing Right to Try into law at a White House ceremony on May 30. (Photo by Michael Coleman/Albuquerque Journal)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/eu-chmp-recommend-approval-tegsedi-inotersen-for-fap-treatment/</loc><lastmod>2018-06-05T13:38:36-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/erdc2018-when-treating-rare-disease-patients-dont-overlook-quality-of-life-panel-urges/</loc><lastmod>2018-05-29T07:00:28-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/05/AT-034.jpg</image:loc><image:title><![CDATA[AT-034]]></image:title><image:caption><![CDATA[A word cloud formed by participants attending a May 11 panel discussion on quality of life issues for rare disease patients.]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/vyndaqel-fails-prevent-oculomeningovascular-amyloidosis-progression-case-report/</loc><lastmod>2018-05-24T09:58:09-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/05/shutterstock_740329909_zpsulhladwh.jpg</image:loc><image:title><![CDATA[shutterstock_740329909_zpsulhladwh]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/rare-impact-awards-dinner-marks-orphan-drug-act-and-nord-at-35/</loc><lastmod>2018-05-17T09:15:29-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/05/aa.jpg</image:loc><image:title><![CDATA[aa]]></image:title><image:caption><![CDATA[NORD Summit, Washington. (Photo by Larry Luxner)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/ecrd2018-eu-must-do-more-for-rare-disease-patients-eurordis-leaders-say/</loc><lastmod>2018-05-17T07:00:11-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/05/Eurordis-booth-at-organizations-May-10-12-rare-disease-meet-in-Vienna.-Photo-by-Larry-Luxner.jpg</image:loc><image:title><![CDATA[Eurordis 2018]]></image:title><image:caption><![CDATA[Eurordis booth at organization&#039;s May 10-12 rare disease meet in Vienna. (Photo by Larry Luxner)]]></image:caption></image:image><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/05/Eurordis-booth-at-organizations-May-10-12-rare-disease-meet-in-Vienna.-Photo-by-Larry-Luxner.jpg</image:loc><image:title><![CDATA[Eurordis 2018]]></image:title><image:caption><![CDATA[Eurordis booth at organization&apos;s May 10-12 rare disease meet in Vienna. (Photo by Larry Luxner)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/rare-mutation-identified-late-onset-fap-libyan-patient-case-report/</loc><lastmod>2018-05-08T09:40:40-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/ecrd2018-patient-access-and-collaboration-focus-of-eurordis-meeting-may-10-12/</loc><lastmod>2018-05-04T07:30:19-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/05/Vienna.jpg</image:loc><image:title><![CDATA[Vienna]]></image:title><image:caption><![CDATA[Panoramic view of Vienna. (Photo by Larry Luxner)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/vyndaqel-slows-nerve-cell-damage-improves-quality-life-fap-patients-study/</loc><lastmod>2018-05-03T13:42:00-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/studies-protein-interaction-aggregation-treatment-fap-other-amyloid-diseases/</loc><lastmod>2018-04-23T12:55:59-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/akcea-completes-deal-that-gives-it-global-rights-tto-fap-therapy-inotersen/</loc><lastmod>2018-04-19T09:24:28-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/aan2018-fap-linked-to-serious-heart-rate-control-abnormalities/</loc><lastmod>2018-04-17T15:22:19-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/04/shutterstock_234033241-e1523980228133.jpg</image:loc><image:title><![CDATA[shutterstock_234033241]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/nih-agency-pioneers-collaborative-research-into-rare-diseases/</loc><lastmod>2018-04-12T11:36:32-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/04/NCATS-office.jpg</image:loc><image:title><![CDATA[NCATS office]]></image:title><image:caption><![CDATA[Office of Rare Diseases Research at NCATS in Bethesda, Maryland. (Photo by Larry Luxner)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/rare-fap-mutation-shows-up-several-times-in-one-japanese-region/</loc><lastmod>2018-04-12T11:30:26-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/04/mutation.jpg</image:loc><image:title><![CDATA[mutation]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/ttr-fap-study-combination-of-three-tests-can-spot-disease-early/</loc><lastmod>2018-04-10T11:58:48-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/certain-people-risk-fap-may-benefit-psychological-support/</loc><lastmod>2018-04-03T11:09:45-05:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/ionis-shares-latest-results-regarding-inotersen-development-fap/</loc><lastmod>2018-03-29T07:00:47-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/03/shutterstock_190598567.jpg</image:loc><image:title><![CDATA[shutterstock_190598567]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/familial-amyloid-polyneuropathy-candidate-inotersen-ionis-akcea-marketing-partnership/</loc><lastmod>2018-03-20T12:48:30-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/03/shutterstock_302764841.jpg</image:loc><image:title><![CDATA[shutterstock_302764841]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/genome-sequencing-and-its-clinical-potential-focus-of-nyc-rare-disease-day-event/</loc><lastmod>2018-04-09T10:54:14-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/03/NY-443.jpg</image:loc><image:title><![CDATA[NY-443]]></image:title><image:caption><![CDATA[Dr. Tuuli Lappalainen of Columbia University speaks at the New York Genome Center. (Photo by Larry Luxner)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/standardized-measures-needed-in-fap-to-assess-autonomic-involvement/</loc><lastmod>2018-03-15T14:48:08-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/03/shutterstock_696833128.jpg</image:loc><image:title><![CDATA[shutterstock_696833128]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/a-disease-may-be-rare-hope-should-never-be-says-boy-with-smard-at-connecticut-rare-disease-day-event/</loc><lastmod>2018-04-09T10:53:49-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/03/Hunter-Pageau.jpg</image:loc><image:title><![CDATA[Hunter Pageau]]></image:title><image:caption><![CDATA[Hunter Pageau, 12, of Connecticut has a very rare form of SMA. He spoke in Hartford on Feb. 28, Rare Disease Day. (Photo by Larry Luxner)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/imaging-agent-mibg-helps-detect-cardiac-involvement-fap-patients/</loc><lastmod>2018-03-13T15:51:26-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/03/shutterstock_578131801-e1520951372177.jpg</image:loc><image:title><![CDATA[shutterstock_578131801]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/rare-disease-groups-welcome-fdas-embrace-real-world-data-clinical-trials/</loc><lastmod>2018-04-09T10:53:14-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/03/admin-ajax.jpg</image:loc><image:title><![CDATA[MD-817]]></image:title><image:caption><![CDATA[Kate Stringaris, a researcher with the NIH&#039;s National Heart, Lung and Blood Institute in Bethesda, Maryland, separates lymphocytes from a blood sample as part of an investigation into natural killer immune cells. ]]></image:caption></image:image><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/03/admin-ajax.jpg</image:loc><image:title><![CDATA[MD-817]]></image:title><image:caption><![CDATA[Kate Stringaris, a researcher with the NIH&apos;s National Heart, Lung and Blood Institute in Bethesda, Maryland, separates lymphocytes from a blood sample as part of an investigation into natural killer immune cells. ]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/us-lawmakers-urge-bipartisan-support-rare-disease-research-patients-needs/</loc><lastmod>2018-04-09T10:52:47-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/03/MD-810-300x200.jpg</image:loc><image:title><![CDATA[MD-810]]></image:title><image:caption><![CDATA[Rep. Leo Lance (R-NJ) speaks at NIH in Bethesda, Md. (Photo by Larry Luxner)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/retrophin-horizon-donate-3m-rare-disease-institute-childrens-national/</loc><lastmod>2018-04-09T10:51:21-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/03/Dr.-Marshall-Summar.jpg</image:loc><image:title><![CDATA[Dr.-Marshall-Summar]]></image:title><image:caption><![CDATA[Dr. Marshall Summar is director of Children&#039;s National&#039;s Rare Disease Institute. (Photo courtesy Children&#039;s National)]]></image:caption></image:image><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/03/Dr.-Marshall-Summar.jpg</image:loc><image:title><![CDATA[Dr.-Marshall-Summar]]></image:title><image:caption><![CDATA[Dr. Marshall Summar is director of Children&apos;s National&apos;s Rare Disease Institute. (Photo courtesy Children&apos;s National)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/bionews-to-cover-3-rare-disease-day-events-including-nih-conference/</loc><lastmod>2018-04-09T10:50:47-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/02/NYGCfeature.jpg</image:loc><image:title><![CDATA[NYGCfeature]]></image:title><image:caption><![CDATA[New York Genome Center (Photo courtesy of NYGC)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/shire-microsoft-eurordis-partner-shorten-multiyear-diagnosis-rare-diseases/</loc><lastmod>2018-02-22T13:09:17-06:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/02/shutterstock_611747507.jpg</image:loc><image:title><![CDATA[shutterstock_611747507]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/patient-advocacy-groups-worldwide-plan-events-mark-rare-disease-day-feb-28/</loc><lastmod>2018-04-09T10:50:10-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/02/RDDfeaturepic.jpg</image:loc><image:title><![CDATA[RDDfeaturepic]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/new-mouse-model-displays-early-stages-of-familial-amyloid-polyneuropathy/</loc><lastmod>2018-02-15T07:39:40-06:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/02/shutterstock_521025469.jpg</image:loc><image:title><![CDATA[shutterstock_521025469]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/rare-disease-groups-patients-differ-right-try-bill-us-congress/</loc><lastmod>2018-04-09T10:49:38-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/02/PenceJordan.jpg</image:loc><image:title><![CDATA[PenceJordan]]></image:title><image:caption><![CDATA[Duchenne muscular dystrophy patient Jordan McLinn jokes with then-Indiana Gov. Mike Pence as he signs that state&#039;s Right to Try bill into law in March 2015. (Photo courtesy of the Goldwater Institute)]]></image:caption></image:image><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/02/PenceJordan.jpg</image:loc><image:title><![CDATA[PenceJordan]]></image:title><image:caption><![CDATA[Duchenne muscular dystrophy patient Jordan McLinn jokes with then-Indiana Gov. Mike Pence as he signs that state&apos;s Right to Try bill into law in March 2015. (Photo courtesy of the Goldwater Institute)]]></image:caption></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/portuguese-study-reports-that-changes-in-walking-patterns-could-help-predict-fap/</loc><lastmod>2018-02-01T07:33:37-06:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/01/shutterstock_616425206.jpg</image:loc><image:title><![CDATA[shutterstock_616425206]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/nord-fundraiser-sets-7000-mile-bike-run-walk-goal-7000-rare-diseases/</loc><lastmod>2018-04-09T10:49:03-05:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/01/DX-513.jpg</image:loc><image:title><![CDATA[DX-513]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/unique-ttr-fap-variations-in-japan-lead-to-country-specific-diagnosis-and-treatment-guidelines/</loc><lastmod>2018-01-23T08:45:07-06:00</lastmod></url>
<url><loc>https://amyloidosisnewstoday.com/news/vyndaqel-may-not-protect-fap-patients-against-anemia-small-japanese-study/</loc><lastmod>2018-01-16T11:51:19-06:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/01/shutterstock_573422434.jpg</image:loc><image:title><![CDATA[shutterstock_573422434]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/alnylam-and-sanofi-dissolve-their-familial-amyloid-polyneuropathy-therapy-partnership/</loc><lastmod>2018-01-11T12:11:23-06:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/01/shutterstock_530971462.jpg</image:loc><image:title><![CDATA[shutterstock_530971462]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/ionis-fap-therapy-inotersen-new-drug-application-granted-fda-priority-review/</loc><lastmod>2018-01-09T07:58:40-06:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/01/shutterstock_418713622-1.jpg</image:loc><image:title><![CDATA[shutterstock_418713622]]></image:title></image:image><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/01/shutterstock_418713622.jpg</image:loc><image:title><![CDATA[shutterstock_418713622]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/surgical-joint-fusion-is-effective-treatment-for-fap-patient-with-rare-knee-deformity-in-case-report/</loc><lastmod>2018-01-04T09:46:55-06:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2018/01/shutterstock_679786771.jpg</image:loc><image:title><![CDATA[shutterstock_679786771]]></image:title></image:image></url>
<url><loc>https://amyloidosisnewstoday.com/news/study-identifies-tests-for-early-diagnosis-of-transthyretin-familial-amyloid-polyneuropathy/</loc><lastmod>2018-01-02T11:39:43-06:00</lastmod><image:image><image:loc>https://amyloidosisnewstoday.com/wp-content/uploads/2017/12/shutterstock_698593141.jpg</image:loc><image:title><![CDATA[shutterstock_698593141]]></image:title></image:image></url>
</urlset>
